The company’s restructuring efforts yielded a gross margin of 10.21%, up from 3.41% in the prior fiscal year. By shedding standardized traffic-related services, Datasea significantly reduced its cost of revenues, which fell by 47.2%. This efficiency drive extended to operating expenses, which decreased by 15% even as the firm aggressively funneled resources into innovation. Research and development spending jumped 180.3% to $2.57 million, targeting advancements in NeuroVibe, biofeedback, and brain-computer interface technologies.

These adjustments improved the bottom line, with net loss narrowing 57% to $2.19 million. Operating cash flow also turned positive, reaching $1.98 million compared to a $2.37 million outflow in 2025. CEO Zhixin Liu noted that while revenue volume decreased, the underlying quality of the business has strengthened. Alongside these financial results, the company secured a 180-day extension from Nasdaq to regain compliance with minimum bid price requirements, setting a new deadline of March 22, 2027.